Skip to main content

Pharmaceutical Sciences Notes

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05102 Law and Policies in Pharmacy Practice

Tanzania Food and Cosmetics Act, 2003 Regulating Distribution and Use of Medicines and Medical Supplies – PST05102 Law and Policies in Pharmacy Practice

NTA Level 5 • Semester 1 • PST05102 Tanzania Food and Cosmetics Act, 2003 Regulating Distribution and Use of Medicines and Medical Supplies Law and Policies in Pharmacy Practice • Source Session/Topic 20 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 20: Tanzania Food and Cosmetics Act, 2003 Regulating Distribution and Use of Medicines and Medical Supplies Total Session Time: 60 minutes Prerequisites None Learning Tasks By the end of this session students are expected to be able to: Define Distribution of medicine and medical supplies Medicine administer Explain sections in TFDC Act, 2003 which regulates distribution, use of medicines and medical supplies. Resources Needed: Flip charts, marker pens, and masking tape Black/white board and chalk/whiteboard markers SESSION OVERVIEW Step Time Activity/ Method Content 1 5 minutes Presentation Introduction, Learning Tasks 2 15 minutes Buzzing Presentation Definition of Distribution and Administration of Medicines and Medical Supplier 3 30 minutes Presentation Explanation of Sections in TFDC Act, 2003 which Regulate Distribution, Use of Medicines and Medical Supplies. 4 5 minutes Presentation Key Points 5 5 minutes Presentation Evaluation SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning Tasks and clarify ASK students if they have any questions before continuing. STEP 2: Definition of Terms. (15 minutes) Activity: Buzzing (20 minutes) ASK students to pair up and buzz on the following question for 2 minutes What does distribution of medicines mean? What is administration of medicines and medical supplies? ALLOW few pairs to respond and let other pairs to add on points not mentioned WRITE their response on the flip chart/board CLARIFY and SUMMARIZE by using the content below Distribution – means a business of dealing in human medicines or medical devices in bulk or wholesale but does not include importers of human medicine, medical devices, food, cosmetics and veterinary medicines.(Pharmacy Act,2011) Administer – means administering of substance or article to a human being or an animal whether orally, by injection or by introduction into the body in any other way, or by external application, whether by direct contact with the body or not and any reference in this Act to administering a substance or article shall be construed as a reference to administering it either in its existing state or after it has been dissolved or dispersed in, sprayed, or diluted or mixed with, some other substance used as a vehicle for such administration.(TFDC Act,2003) STEP 3: Sections in TFDC Act, 2003 which Regulate Distribution, Use of Medicines and Medical Supplies. (45 minutes) Section 24- supplying and dispensing drugs Subsection (1) A medical practitioner, dentist or veterinary surgeon, or a member of the staff of a hospital, dispensary or similar institution who has been authorized to do so by the general or special order of the Minister, on the advice of the Authority may supply or dispense a prescription drug for the purpose of medical, dental or veterinary treatment, as the case may be, subject to the following conditions – The drug shall be distinctly labelled with the name and address of the person by whom it is supplied or dispensed; The following particulars shall, within twenty four hours after the drug has been supplied or dispensed, be entered in a book used Regularly for the purpose, and which shall be called the Prescription Book the date on which the drug was supplied or dispensed; the name, strength and the quantity supplied; the name and address of the person to whom the drug was supplied; The name and address of the person by whom the prescription was given. Subsection (2) where an authorized seller of drugs supplies a prescription drugs, shall enter its particulars in a Prescription Book kept in accordance with the provisions of this section. Subsection (3) Any person to whom subsection (1) applies and who supplies or dispenses any prescription drug in a manner contrary to this section, commits an offence and upon conviction is liable to a fine of not less than one hundred thousand shillings or to imprisonment for a term not exceeding one month, or to both such fine and imprisonment. Section 26.Licence to sell, supply or dispense. Subsection (1) Notwithstanding any of the provisions of this Act, relating to sell, supply or dispensing of drugs and if it is in the public interest so to do, the Minister may, on advise of the Authority and by order published in the Gazette, allow any person or group of persons to be licensed by the Authority to sell, supply or dispense such drugs as may be specified and under such conditions as may be prescribed in the regulations. Subsection (2) The Minister may in addition to any other conditions, require such a person to possess specified qualifications or training as the case may be. Section 27.Authority to issue dispensing certificate specified drugs. Subsection (l) The Authority may, when it is in the public interest and upon an application being made in a prescribed manner and subject to such conditions as may be prescribed in the regulations made under this Act, issue a dispensing certificate to a practicing medical practitioner, dentist or veterinary surgeon to dispense drugs, which he is entitled to prescribe. Subsection (2) upon application being made to the Authority pursuant to subsection (1), the Authority may issue a dispensing certificate subject to such conditions as it may deem necessary and for such duration of time as it may prescribe. Subsection (3) The Authority may, where it is satisfied that the applicant did not or is not fulfilling the conditions issued by it may suspend, revoke or withdraw the dispensing certificate issued under subsection (1) of this section Subsection (4) in this section ''public interest'' means and includes facilitation of accessibility of the public to drugs within a specified area. Section 86. No cosmetics shall be sold, given, manufactured, imported, stored or

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

Introduction to Microbiology – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 Introduction to Microbiology Pharmaceutical Microbiology • Source Session/Topic 1 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 1: Introduction to Microbiology Total Session Time: 60 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • Define terms used in microbiology • Explain the history and development of microbiology Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 | |Presentation |Terminologies used in | | |10 minutes | |Pharmaceutical Microbiology | |3 |35 minutes |Presentation |History and development of | | | | |microbiology | |4 |5 minutes |Presentation |Key Points | |5 |5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Common Terminologies Used in Pharmaceutical Microbiology (10 minutes) • Microorganisms o Microorganisms are organisms that are too small to be seen by naked eyes o Microorganisms include viruses, bacteria, fungi, protozoa and algae. • Microbiology • Microbiology is the study of microorganisms which must be viewed with the aid of a microscope or electron microscope • Pharmaceutical microbiology o This deals with the study of microorganisms of pharmaceutical importance • Bacteriology o Is the study of bacteria • Mycology o Is the study of fungi • Protozoology o Is the study of protozoans • Virology o Is the study of viruses STEP 3: History and Development of Microbiology (35 minutes) • 1660’s Robert Hooke observed microorganisms for the first time with a microscope and coined the term “cell”. • 1632-1723 Anton van Leeuwenhoek credited with having observed the first bacteria. • 1828-1898 Ferdinand Cohn developed the first classification scheme based on bacteria shape. Cohn detailed and described the life cycle of Bacillus. Cohn’s Classification System: o Sphaerobacteria are spherically shaped. o Microbacteria are rod shaped o Desmobacteria are filamentous o Spirobacteria are spiral shaped • 1822-1895 Louis Pasteur Defined pasteurization to prevent spoilage of food by bacteria, develop vaccines and disproved the scientific dogma of “Spontaneous Generation”. He defined “Germ Theory” and demonstrated that germs were responsible for disease. • 1843-1910 Robert Koch identified anthrax and developed agar growth medium. Koch’s postulates was a systematic method to establish the microbial cause of disease. • Ignaz Semmelweis was the first to recognize the need for good hygiene during medical procedures. The first to identify nosocomial infections. • 1827-1912 Joseph Lister developed antiseptic methods for use in surgery and medicine. • 1854-1915 Paul Ehrlich developed chemotherapy to cure infectious diseases and discovers antibiotics to treat sleeping sickness and syphilis. • 1881-1951 Alexander Fleming discovered penicillin and lysozyme. • 1864-1920 Dmitri Ivansvski discovered the first virus which is known as the tobacco mosaic virus (TMV). • 1952 Hershey & Chase Experiments identified that DNA was the genetic material of bacteriophages. • Hershey Case Experiment: using phage radioactively labeled with P32 (DNA) or S35 (protein) they infected bacteria cells. They found the P32 inside the bacteria not S35. STEP 4: Key Points (5 minutes) • Microorganisms are minute living things that are too small to be seen by the naked eye. • Microbiology is the scientific study of microorganisms • Pharmaceutical microbiology is the scientific study of microorganisms of pharmaceutical importance STEP5: Evaluation (5 minutes) • What is a microorganism? • What is the difference between microbiology and biology? • Who is the father of microbiology? • Give important land marks in the history of microbiology References Hugo and Russell (2011), Pharmaceutical Microbiology 8th Edition, Willey- Blackwel publications Karen C. Carroll et al (2013); Jawetz, Melnick and Adelberg’s Medical Microbiology 26th Ed. McGraw Hill Co. Inc. Greenwood et al (2012); Medical Microbiology, 18th edition Churchill Livingstone Next Topic →View all Pharmaceutical Microbiology topicsOpen Complete Full Notes PDF / OFFLINE NOTES Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP WhatsApp: 255620339260

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

Classification and importance of Micro organisms – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 Classification and importance of Micro organisms Pharmaceutical Microbiology • Source Session/Topic 2 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 2: Classification and importance of Micro organisms Total Session Time: 120 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • Differentiate between eukaryotic and prokaryotic cells • Explain classification and nomenclature of microorganisms • Explain the importance of microorganisms in pharmacy Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 | |Small group |Differences between eukaryotic and| | |30 minutes |discussion/ |prokaryotic cells | | | |Presentation | | |3 |50 minutes |Buzzing/ |Classification and nomenclature of| | | |Presentation |microorganisms | |4 |25 minutes |Presentation |Importance of microorganisms in | | | | |pharmacy | |5 |5 minutes |Presentation |Key Points | | 6|5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Differences between eukaryotic and prokaryotic cells (30 minutes) |Activity: Small Group Discussion (10 minutes) | | | |DIVIDE students into small manageable groups | | | |ASK students to discuss on the following question | |What are the differences between eukaryotic and prokaryotic cells? | | | |ALLOW students to discuss for 10 minutes | | | |ALLOW few groups to present and the rest to add points not mentioned| | | | | |CLARIFY and SUMMARIZE by using the contents below | All living things are made up of cells and cells are the smallest units of any living organism. All cells are grouped into two major groups, eukaryotic and prokaryotic cells. The differences between eukaryotic cells and prokaryotic cells are summarized as follow: |Eukaryotic Cells |Prokaryotic Cells | |Larger than eukaryotic cells |Small than eukaryotic cells | |(>10um) |(<5um) | | have no rigid cell wall | have rigid cellwall | |Always have nucleus and other |No nucleus or any other | |membrane-bound organelles |membrane-bound organelles | |DNA is linear |DNA is circular, | |Ribosomes are larger (80S) |Ribosomes are small (70S) | |Have cytoskeleton |No cytoskeleton | |Move by cilia or flagella |Move by flagella | |Cell division is by mitosis or |Cell division is by binary | |meiosis |fission | |Reproduction is asexual or sexual |Reproduction is always asexual | Figure 2.1: Prokaryotic Cell [pic] Figure 2.2: Eukaryotic Cell [pic] STEP 3: Classification and nomenclature of microorganisms (50 minutes) |Activity: Buzzing (5 minutes) | | | |ASK students to pair up and buzz on the following question for 2 | |minutes | | | |What is classification of microorganisms? | | | |ALLOW few pairs to respond and let other pairs to add on points not | |mentioned | | | |WRITE their response on the flip chart/board | | | |CLARIFY and SUMMARIZE by using the content below | • Microorganisms or microbes are microscopic organisms that exist as unicellular, multicellular, or cell clusters • Microorganisms are widespread in nature and are beneficial to life, but some can cause serious harm • Microorganisms are systematically classified into taxonomic categories to facilitate research and communication • Biologic classification helps identify each form according to common properties (similarities) using a set of rules and an estimate as to how closely related it is to a common ancestor (evolutionary relationship) in a way to create an order • The first, largest, and most inclusive group under which organisms are classified is called a domain o The domain has three subgroups: bacteria, archae, and eukarya o This first group defines whether an organism is a prokaryote or a eukaryote • The second largest group is called a kingdom o There are five major kingdoms and include prokaryota (e.g. archae and bacteria), protoctista (e.g. protozoa and algae), fungi, plantae, and animalia o A kingdom is further split into phylum or division, class, order, family, genus, and species, which is the smallest group • The classification of microorganisms in these taxa employ; • Microscopic morphology • Macroscopic morphology – colony appearance • Physiological / biochemical characteristics • Chemical analysis • Serological analysis • Genetic and molecular analysis o G + C base composition o DNA analysis using genetic probes o Nucleic acid sequencing and rRNA analysis • Generally, microorganisms can be divided into six major types: bacteria, archaea, fungi, protozoa, algae, and viruses • Bacteria o Bacteria are unicellular organisms described as prokaryotic because they lack a nucleus o They exist in four major shapes: bacillus (rod shape), coccus (spherical shape), spirilla (spiral shape), and vibrio (curved shape) o Most bacteria have a peptidoglycan cell wall; they divide by binary fission; and they may possess flagella for motility o The difference in their cell wall structure is a major feature used in classifying them o According to the way their cell walls structure stains, bacteria can be classified using the Gram-staining as either ▪ Gram-positive ▪ Gram-negative o Bacteria can be further divided based on their response to gaseous oxygen into the following groups: ▪ aerobic (living in the presence of oxygen) ▪ anaerobic (living without oxygen) ▪ facultative anaerobes (can live in both environments) o According to the way they obtain energy, bacteria are classified as heterotrophs or autotrophs ▪ Autotrophs make their own food by using the energy of sunlight or chemical reactions, in which case they are called chemoautotrophs ▪ Heterotrophs obtain their energy by consuming other organisms. Bacteria that use decaying life forms as a source of energy are called saprophytes. • Viruses o Viruses are noncellular entities that consist of

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

Introduction to Bacteria – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 Introduction to Bacteria Pharmaceutical Microbiology • Source Session/Topic 3 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 3: Introduction to Bacteria Total Session Time: 120 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • Define terms used in bacteria • Describe bacterial occurrences and distributions • Classify bacterial according to staining properties, nutritional requirements and morphology Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 |20 minutes |Presentation |Common Terminologies used in | | | | |bacteriology | |3 |30 minutes |Presentation |Bacterial Growth and Reproduction | |4 |20 minutes |Presentation |Characteristics of Bacteria | |5 |35 minutes |Presentation |Classification of Bacteria | |6 |5 minutes |Presentation |Key Points | | 7|5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Common Terminologies Used in Bacteriology (20 minutes) • Bacteriology o Bacteriology is the study of bacteria • Bacteria o Bacteria are prokaryotic organisms that replicate by binary fission. Other prokaryotic organisms are the archaea • Bacteriostatic o A substance that inhibit replication or growth of bacteria • Bactericidal o A substance that kills the bacteria • Growth medium o A blend of nutrients where microorganisms are made to grow in the laboratory • Staining o Is the process of applying dyes to a smear of microorganisms fixed on slide in order to make certain structures visible • Microbiota o Microbial flora harboured by normal, healthy individuals • Pathogenicity o The ability of an infectious agent to cause disease • Pathogen o A microorganism capable of causing disease • Opportunistic pathogen o An agent capable of causing disease only when the host’s immunity is impaired • Infection o Multiplication of an infectious agent within the body. Multiplication of the bacteria that are part of the normal microbiota of the gastrointestinal tract, skin, and so on is generally not considered an infection • Toxigenicity o The ability of a microorganism to produce a toxin that contributes to the development of disease • Virulence o The quantitative ability of an agent to cause disease. Virulent agents cause disease when introduced into the host in small numbers. Virulence involves adherence, persistence, invasion, and toxigenicity • Carrier o A person or animal with asymptomatic infection that can be transmitted to another susceptible person or animal STEP 3: Bacterial Growth and Reproduction (30 minutes) • In bacteria growth an increase in number of cells or biomass. They increase in number via reproduction by binary fission • Bacteria population grow in exponential fashion. One cell produces two daughter cells and the two daughter cells produce four cells and so forth. • The time interval between one cell division and the next is called generation time • Bacteria growth can occur on solid surfaces (e.g. on agar plate) or in liquid (e.g. broth) • Growth in bacteria can be in open or closed culture • Bacteria growth in closed culture (closed batch liquid culture) show the following phases of growth; o Lag phase or adaptive phase o Logarithmic phase or exponential phase o Stationary phase o Decline phase • Various factors affect bacterial growth • Factors that influence bacterial growth include; o Environmental factors e.g. availability of water, nutrients, pH, oxygen concentration and solute concentration o Physicochemical factors e.g. temperature, pH, solute, availability of oxygen etc. • Optimum growth occurs at very conducive environment • Effect of various factors affecting growth e.g. temperature, can be plotted on growth rate Vs factor to clearly show impact of varying the factor on growth rate o Such plots/graphs include ▪ Growth Vs temperature ▪ Growth Vs pH ▪ Growth Vs oxygen concentration etc. • Bacteria growth requirement in the laboratory are achieved by using nutrients formulated in growth media. These are available commercially for growing different types of bacteria in the laboratory o E.g. MacConkey agar (for Gram negative bacteria), Blood agar (grows a variety of bacteria) etc. • Bacterial growth can be measured by various methods e.g. by counting the number of cells STEP 4: Characteristics of Bacteria (20 minutes) |Activity: Buzzing (5 minutes) | | | |ASK students to pair up and buzz on the following question for 2 | |minutes | | | |What are the characteristics of bacteria? | | | |ALLOW few pairs to respond and let other pairs to add on points | |not mentioned | | | |WRITE their response on the flip chart/board | | | |CLARIFY and SUMMARIZE by using the content below | • They are prokaryotic i.e. they lack nuclear membrane so no true nucleus • Bacteria are unicellular • Cell wall is made up peptidoglycan • Bacteria reproduce by binary fission • DNA is circular • They do not have membrane-bound organelles • Metabolism in bacteria i.e. variety of pathways • Movement in bacteria i.e. flagella STEP 5: Classification of Bacteria (35 minutes) • Bacteria are classified according to different criteria • Morphology o Microscopic appearance of cells i.e. bacteria are classified according to their shapes o Cocci ▪ Bacteria that are spherical in shape. They include; • Streptococci (singular: Streptococcus) –Spherical bacteria in chains • Staphylococci (singular: Staphylococcus) –Spherical bacteria in clusters • Diplococci (singular: diplococcus) –Spherical bacteria in pairs o Bacilli ▪ Bacteria that are rod-shaped or cylindrical bacteria. They include; • Streptobacilli (in chains) • Coccobacilli –short round rods, oval and they look like cocci o Spirillum ▪ Bacteria are spiral in shape o Vibrio ▪ Bacteria are comma-shaped i.e. curved-rods o Spirochete

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

Internal structures and drug targets in prokaryotic cells – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 Internal structures and drug targets in prokaryotic cells Pharmaceutical Microbiology • Source Session/Topic 4 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 4: Internal structures and drug targets in prokaryotic cells Total Session Time: 120 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • Describe the structure of a bacterial cell • List functions of different bacterial organelles/structures • Describe various drug targets in the bacterial cell Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 |80 minutes |Group |Description of Internal Structures| | | |discussion/ |of Bacteria | | | |Presentation | | |3 |25 minutes |Presentation |Drug Targets | |4 |5 minutes |Presentation |Key Points | | 5|5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Internal Structures of Prokaryotic Cells (80 minutes) • Bacteria are one group of prokaryotes, the other group is the archaea • Bacterial structure can be described in terms of external and internal structures • Internal structures of bacterial cells are those internal to the cell wall • The bacterial cell wall and its associated structures comprise the external structures of the bacterial cell |Activity: Small Group Discussion (40 minutes) | | | |DIVIDE students into small manageable groups | | | |ASK students to discuss on the following question | |Draw a labeled diagram showing internal structures of a bacterial | |cell | |List the function(s) of each of the labeled structure | | | |ALLOW students to discuss for 30 minutes | | | |ALLOW few groups to present and the rest to add points not | |mentioned | | | |CLARIFY and SUMMARIZE by using the contents below | • The internal structure of a prokaryotic cell consists of the cytoplasm which contains enzymes needed for metabolic reactions. [pic] Source: https://www.slideshare.net/mdsalaadx1/anatomy-and-physiology- of-bacteria The Cytoplasm • The cytoplasm is an aqueous thick fluid enclosed by the cell membrane • It is made up of 80% water, and proteins (enzymes), carbohydrates, lipids, inorganic ions and many low-molecular-weight compounds • Fills the cell and it is where most cellular reactions and activities take place • It is the internal environment of the cell The cell membrane • The cell membrane is located immediately beneath the cell wall • The cell membrane is a thin membrane around the cytoplasm • The cell membrane is also called the cytoplasmic membrane or plasma membrane • It contains phospholipids, proteins and polysaccharides • The cell membrane is a vital structure and critical barrier that separates the inside of the cell from the outer environment • The gram positive bacteria have one plasma membrane while the gram negative bacteria have two plasma membranes –one is internal and the second is known as an outer membrane separated from the inner membrane by the periplasmic space Figure 4.1: Cell membrane in Gram positive and Gram negative bacteria [pic] • Functions of plasma membrane; o The plasma membrane retains the cytoplasm, particularly in cells without cell walls, and separates it from the surroundings o Plasma membranes serve as a selectively permeable barrier; it allows particular ions and molecules to pass, either into or out of the cell, while preventing the movement of others o Transport systems can be used for such tasks as nutrient uptake, waste excretion, and protein secretion o The plasma membrane also is the location of a variety of crucial metabolic processes; respiration, photosynthesis, the synthesis of lipids and cell wall constituents, and probably chromosome segregation. Mesosomes • In gram positive bacteria, the plasma membrane forms in folding • The infolding form structures called mesosomes within cytoplasm • The mesosomes are associated with bacterial nuclear material and its replication • Respiratory enzymes are also associated with mesosomes • Functions of mesosomes o They are imvolved in cell wall formation during cell division. o They play a role in replication of chromosome and distribution to daughter cells. o They are also involved in secretary processes Nucleoid • Nucleoid is an area within the cytoplasm of a prokaryotic cell where DNA is located • It is equivalent to the nucleus in eukaryotic cells • It is not enclosed in a membrane i.e. no nuclear membrane (not a true nucleus) but it is visibly separate from the rest of the cell interior. • The bacterial DNA is single-stranded, circular and haploid Plastids • Prokaryotic cells do not have mitochondria or chloroplast o The electron transport enzymes are located in the cytoplasmic membrane o Photosynthetic pigments (Carotenoids, bacterial chlorophyll) of photosynthetic bacteria are located below the cell membrane o In some Cyanobacteria (blue-green algae), the photosynthetic structures are called Thylakoids o Thylakoids contain light harvesting pigments called phycobilins o Plastids provide energy for the prokaryotic cell as well as carrying out photosynthesis process in cyanobacteria Inclusion or storage granules • Inclusion granules are storage structures within the bacterial cytoplasm • There are several types of storage granules for nutrients in prokaryotic cells o i.e. they serve as energy and nutrient reservoirs • Nutrients may be stored in the cytoplasm in the form of lipids, glycogen, polyphosphate (and sometimes sulphur (volutin granules) or nitrogen • When source of nitrogen, sulphur, or phosphorus is limited or when pH is low, excess CO2 in the medium may be converted to “Poly-β- hydroxybutric acid, starch and glycogen which are used as energy sources Endospores • Some bacteria (e.g. Clostridium) form spores that are very resistant to drought, high temperatures and other hazards of

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

External structures and drug targets in prokaryotic cells – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 External structures and drug targets in prokaryotic cells Pharmaceutical Microbiology • Source Session/Topic 5 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 5: External structures and drug targets in prokaryotic cells Total Session Time: 120 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • Describe the structure of a bacterial cell • List functions of different bacterial organelles/structures • Describe various drug targets in the bacterial cell Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 |50 minutes |Presentation |External structures of prokaryotic| | | | |cells | |3 |25 minutes |Presentation |Drug Targets in Bacterial Cell | | | | |Wall | |4 |30 minutes |Presentation |Acid fast Bacilli | |5 |5 minutes |Presentation |Key Points | | 6|5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Bacterial External Structures and Drug Targets (50 minutes) • Bacterial External Structures o External structures include the cell wall and structures external to it • Bacterial Cell wall o A cell wall is a layer located outside the cell membrane found in plants, fungi, bacteria, algae, and archaea. o The bacterial cell wall is a rigid structure outside the cell membrane (and inner to the capsule for capsulated bacteria) composed of peptidoglycan layers making up a cell envelope around the cell o Peptidoglycan is composed of disaccharides and amino acids which gives structural support to the bacteria o Peptidoglycan is unique to bacteria Figure 5.1: Structure of Peptidogycan [pic] ▪ Molecules making up the peptidoglycan include; • Alternating NAM and NAG chains • A tetrapeptide chain • A petaglycin chain [pic] o Bacteria are classified as being either Gram-positive or Gram- negative based in differences in the structure of their peptidoglycan cell wall o Gram-positive bacteria are stained dark blue or violet by Gram staining o In Gram-positive bacteria, the cell wall is thick and consists of several layers of peptidoglycan o Gram negative bacteria lack the outer membrane envelope found in Gram-negative bacteria ▪ They contain teichoic acids in the peptidoglycan. • Teichoic acids are unique to the Gram-positive cell wall • Teichoic acids are linear polymers of polyglycerol or polyribitol substituted with phosphates and a few amino acids and sugars ▪ immune response when the bacteria infect animals o Functions of the bacterial cell wall; ▪ To enclose and protect the internal structures ▪ To protect the bacteria from osmotic lysis ▪ Provide shape to the bacteria • Structures external to the cell wall include; ▪ Flagella • Flagella are long protein filaments of uniform length that are responsible for cell motility • They are whip-like structure that allows a cell to move • Types and examples of flagella o Monotrichous –Single polar flagellum e.g. Vibrio cholerae o Amphitrichous –Single flagellum on both sides e.g. Alkaligens faecalis o Lophotrichous –Tufts of flagella at one or both sides e.g. Spirillum o Peritrichous–Numerous flagella all over the bacterial body ▪ Pili • Pili (singular: pilus) are hair-like appendages found on the surface of some bacteria. They are made up of proteins called pilins • Pilli are classified into Ordinary pili or Sex pili according to their morphology, distribution, and function • The pilus is found on the surface of many gram-positive bacteria and some gram-negative bacteria • Pili function as adhesive factors for mucosal surface attachment ▪ Capsule • A capsule is a discrete detectable layer of polysaccharides deposited outside the cell wall • Capsule is attached tightly to the bacterium and has definite boundaries • Capsules are considered virulence factors because they protect a bacterial cell from ingestion and destruction by white blood cells (phagocytosis) ▪ Slime layer • • A slime layer in bacteria is an easily removable (e.g. by centrifugation), unorganized layer of extracellular material that surrounds bacteria cells • A slime layer is loosely associated with the bacterium and can be easily washed off • The slime layer is usually composed of polysaccharides and it may serve to trap nutrients, to aid in cell motility, to bind cells together or to adhere to smooth surfaces STEP 3: Drug Targets in Bacterial Cell Wall (25 minutes) • Cell Biosynthetic Enzymes o Fosfomycin o Cycloserin • Carrier Molecules o Bacitracin • Cell wall substrates o Vancomycin • Enzymes that Catalyse Crosslinking of peptidoglycan subunits (Transpeptidases) o Penicillins o Cephalosporins o Carbapenems o Monobactams STEP 4: Acid-fast Bacteria (30 minutes) • Acid-Fast Bacteria possess a unique cell wall architecture different from both gram negative and gram positive bacteria • The Acid-Fast cell wall consists of a thick, outer lipid-rich layer composed primarily of the fatty acid "Mycolic Acid" • This lipid layer lies on top of a layer of peptidoglycan and the sugar arabinogalactan which in turn invest the inner lipid membrane common to all bacteria • The thick outer mycolic acid layer renders acid-fast bacteria resistant to gram stain. • When stained with alternative dyes, the cell wall is resistant to decolorization with acid alcohol, thus their name "Acid-Fast” • The cell wall is characterized by; o A thin layer of peptidoglycan [pic] • Function of the Cell wall components of Acid-fast bacilli o The peptidoglycan prevents osmotic lysis o The arabinogalactan layer is linked to both the peptidoglycan and to the mycolic acid outer membrane and probably provides additional strength to the cell wall o The mycolic acids and other glycolipids also impede the entry of chemicals causing the organisms to grow slowly and be more

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

Introduction to Staphylococci – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 Introduction to Staphylococci Pharmaceutical Microbiology • Source Session/Topic 6 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 6: Introduction to Staphylococci Total Session Time: 60 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • List characteristic of the medical Staphylococci Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 |15 minutes |Presentation |Characteristics of Staphylococci | |3 |10 minutes |Presentation |Human Staphylococcal Pathogens | |4 |20 minutes |Presentation |Epidemiology and Pathogenesis of | | | | |the Staphylococci | |5 |5 minutes |Presentation |Key Points | | 6|5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Characteristics of Staphylococci (15 minutes) • Staphylococcus is a genus of Gram-positive spherical bacteria (cocci) which grow in grape-like clusters • Staphylococci are catalase positive (this distinguishes them from Streptococci which are catalase negative). The enzyme catalase breaks down hydrogen peroxide into water and oxygen. • Staphylococci are widely distributed; some are normal flora while others are pathogenic to humans causing many forms of infections. • Staphylococcus aureus colonizes the nasal passage and axillae while Staphylococcus epidermidis is a common human skin commensal. Other species of staphylococci are infrequent human commensals and other animals. • Staphylococci are salt tolerant and often hemolytic • S. aureus and Staphylococcus intermedius are coagulase positive. Coagulase enzyme clots blood plasma • All other staphylococci are coagulase negative STEP 3: Human Staphylococcal Pathogens (10 minutes) • Most staphylococci are not pathogenic to humans • Human pathogens include; o S. aureus ▪ which is the most pathogenic of the staphylococci ▪ leading cause of nosocomial infections o S. epidermidis ▪ Causes infections of prosthetic heart valves and hips ▪ It is a common member of the skin normal flora o S. saprophyticus ▪ Which causes urinary tract infection STEP 4: Epidemiology and Pathogenesis of the Staphylococci (20 minutes) • Infections caused staphylococci include; o Skin infections, pneumonia, endocarditis, osteomyelitis and septic arthritis which are due to direct tissue invasion by the bacteria o Toxic shock syndrome, staphylococcal scalded skin syndrome, staphylococcal food poisoning which are toxin-mediated • S aureus causes many forms of infection in humans; o Superficial skin lesions (boils, styes) and more serious skin infections e.g. furunculosis o Toxin-mediated infections e.g. food poisoning o Localized abscesses o Deep-seated infections, such as osteomyelitis and endocarditis • S. aureus expresses many potential virulence factors o Surface proteins that promote colonization of host tissues o Factors that probably inhibit phagocytosis e.g. capsule, immunoglobulin binding protein o Toxins that damage host tissues and cause disease symptoms • Coagulase-negative staphylococci are normally less virulent and express fewer virulence factors o S. epidermidis are skin normal flora that readily colonize implanted devices e.g. prosthetic heart valves • Pathogenic staphylococci are transmitted by shedding from human lesions and contaminated formites such as clothing and bed linens. Heavily contaminated environment and compromised immunity favour infection by members of the genus • Manifestations of disease caused by Staphylococci are inflammatory and toxin-mediated o Inflammatory manifestations range from superficial skin lesions to deep osteomyelitis to septicaemia • Multiple antibiotic resistance is increasingly common in S. aureus and S epidermidis • Methicillin resistance indicates multiple resistance • Methicillin-resistant S aureus (MRSA) causes outbreaks in hospitals and can be epidemic • Infections acquired outside hospitals can usually be treated with penicillinase-resistant β-lactams • Hospital acquired infections are often caused by antibiotic resistant strains and can only be treated with vancomycin STEP 5: Key Points (5 minutes) • Staphylococci can cause many forms of infection • Staphylococci are Gram-positive cocci 1μm in diameter and grown in grape-like clusters • Staphylococci are catalase positive • S. aureus and S. intermedius are coagulase positive while all other staphylococci are coagulase negative STEP 6: Evaluation (5 minutes) • Mention four characteristics of staphylococci • S. causes which diseases in humans? • How are staphylococcal infections acquired? References Hugo and Russell (2011), Pharmaceutical Microbiology 8th Edition, Willey- Blackwel publications Karen C. Carroll et al (2013); Jawetz, Melnick and Adelberg’s Medical Microbiology 26th Ed. McGraw Hill Co. Inc. Greenwood et al (2012); Medical Microbiology, 18th edition Churchill Livingstone ← Previous TopicNext Topic →View all Pharmaceutical Microbiology topicsOpen Complete Full Notes PDF / OFFLINE NOTES Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP WhatsApp: 255620339260

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

Introduction to Streptococci – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 Introduction to Streptococci Pharmaceutical Microbiology • Source Session/Topic 7 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 7: Introduction to Streptococci Total Session Time: 60 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • List characteristic of the medical Staphylococci Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 | 15 minutes|Buzzing/ |Characteristics of Streptococci | | | |Presentation | | |3 |15 minutes |Presentation |Classification of Streptococci | |4 |5 minutes |Presentation |Human Streptococcal Pathogens | |5 |10 minutes |Presentation |Epidemiology and Pathogenesis of | | | | |Streptococcal Infections | |6 |5 minutes |Presentation |Key Points | | 7|5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Characteristics of Streptococci (15 minutes) |Activity: Buzzing (5 minutes) | | | |ASK students to pair up and buzz on the following question for 2 | |minutes | | | |What are the characteristics of Streptococci? | | | |ALLOW few pairs to respond and let other pairs to add on points | |not mentioned | | | |WRITE their response on the flip chart/board | | | |CLARIFY and SUMMARIZE by using the content below | • Streptococci belong to the genus Streptococcus • Streptococci are Gram positive, non motile, non spore forming cocci that grow in pairs or in chains • They lose their Gram-positive character as the culture grow old • Most are facultative anaerobic but some are obligate anaerobic • Most require enriched media (e.g. blood agar) for their growth • All Streptococci are catalase negative (this distinguish them from Staphylococci which are catalase positive) i.e. Streptococci cannot break down hydrogen peroxide • Streptococci exhibit various degree of red blood cells haemolysis. o Complete haemolysis –β-haemolytic streptococci o Partial haemolysis –α-haemolysis o No haemolysis –γ-haemolysis STEP 3: Classification of Streptococci (15 minutes) • Based on Haemolysis of red blood cells o Three different types of streptococci are initially differentiated by their appearance when they are grown on sheep blood agar ▪ β-haemolytic streptococci • Produce zones of clear haemolysis around each colony ▪ α-haemolytic streptococci • produce partial haemolysis or show green discoloration resulting from incomplete haemolysis ▪ γ-haemolytic streptococci (also known as the Viridans Streptococci) • they are non-haemolytic. • Based on the presence of a specific carbohydrate in their cell wall, streptococci are subsequent classified into Lancefield groups A through H and K through T • Viridans streptococci form a separate group that is difficult to classify by the Lancefield grouping method • In the Lancefield classification, enterococci were initially included among the group D streptococci but now have been classified as a separate genus [pic] Refer students to Figure 9.1: Medically important Streptococci for detailed information on the classification of various Streptococci into Lancefield classification STEP 4: Human Streptococcal Pathogens (5 minutes) • Various members of the Streptococci are normal flora of humans and other animals • Some Streptococci are pathogenic to humans causing acute and chronic diseases • Some pathogenic Streptococci include; o Streptococcus pyogenes o Streptococcus pneumoniae o Streptococcus agalactiae -causes neonatal disease o Viridans streptococci ▪ S. sanguis ▪ S. mutans ▪ S. milleri STEP 5: Epidemiology and Pathogenesis of Streptococcal Infections (10 minutes) • Pathogenic Streptococci cause diseases that range from subacute to acute or even chronic • In humans, diseases associated with the streptococci occur chiefly in the respiratory tract, bloodstream, or as skin infections • Most significant human diseases caused by streptococci are scarlet fever, rheumatic heart disease, glomerulonephritis, and pneumococcal pneumonia • The most significant streptococcal pathogen is S. pyogenes, which is beta-hemolytic and in Lancefield group A and is thus denoted as group A beta-hemolytic streptococci (GABHS)???? o The most common acute diseases due to GABHS are ▪ Pharyngitis (or sore throat) ▪ Skin infections such as impetigo, cellulitis and necrotising fasciitis o In addition, delayed, nonsuppurative complications (rheumatic fever, acute glomerulonephritis) sometimes occur ≥ 2 weeks after infection • Disease caused by other streptococcal species is less prevalent and usually involves soft-tissue infection or endocarditis (Some non-GABHS infections occur predominantly in certain populations (e.g. group B streptococci in neonates and postpartum women) • GABHS can spread through the affected tissues and along lymphatic channels (causing lymphangitis) to regional lymph nodes (causing lymphadenitis) • GABHS can also cause local suppurative complications, such as peritonsillar abscess, otitis media, sinusitis, and bacteremia • Suppuration depends on the severity of infection and the susceptibility of tissue. • Other serious GABHS infections include septicemia, puerperal sepsis, endocarditis, pneumonia, and empyema • Streptococcal infections are transmitted through contact, droplets, food or formites • Portal of entry for the infections are generally the skin or pharynx • Children are predominantly affected for cutaneous and throat infections • Systemic infections and progressive sequela are possible if local infections are left untreated STEP 6: Key Points (5 minutes) • Streptococci are gram positive spherical bacteria (cocci) that occur in chain • Streptococci are catalase negative • Streptococci are classified by their ability to haemolyse red blood cells and presence of specific carbohydrate in their cell walls • Pathogenic streptococci cause a variety of infections due to direct invasion of tissues and toxin-mediated infections • Many skin infections caused by Streptococci are also caused by Staphylococci. STEP 7: Evaluation (5 minutes) • How are streptococci classified? • How do streptococci differ from staphylococci? Figure 9.1: Medically important Streptococci [pic] Source: Medical Microbiology. 4th edition. Baron S, editor. Galveston (TX): University of Texas

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

Staphylococcal and Streptococcal Skin Infections – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 Staphylococcal and Streptococcal Skin Infections Pharmaceutical Microbiology • Source Session/Topic 8 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 8: Staphylococcal and Streptococcal Skin Infections Total Session Time: 120 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • Describe common bacterial diseases (causative agents, transmission, signs and symptoms) • Describe treatment, prevention and control of common staphylococcal and streptococcal diseases Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 | 30 minutes|Presentation |Impetigo | |3 |25 minutes |Presentation |Folliculitis | |4 |20 minutes |Presentation |Farunculosis | |5 |15 minutes |Presentation |Erysipelas | |6 |10 minutes |Presentation |Cellulitis | |8 |10 minutes |Presentation |Key Points | | 7|5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Impetigo (30 minutes) • Cause o Impetigo is a superficial skin infection with crusting or bullae caused by Streptococci, Staphylococci, or both. o Impetigo is commonly caused by Staphylococcus aureus o It affects the subcorneal layer of the epidermis with characteristic honey-colored serous crusts. Ecthyma is an ulcerative form of impetigo o Impetigo commonly occurs in school children, usually starting on the face, especially around the mouth or nose o Impetigo may be bullous or nonbullous ▪ Staphylococcus aureus is the predominant cause of nonbullous impetigo and the cause of all bullous impetigo ▪ Bullae are caused by exfoliative toxin produced by staphylococci • Signs and Symptoms o Nonbullous impetigo typically manifests as clusters of vesicles or pustules that rupture and develop a honey-colored crust (exudate from the lesion base) over the lesions o Bullous impetigo is similar except that vesicles typically enlarge rapidly to form bullae. The bullae burst and expose larger bases, which become covered with honey-colored varnish or crust o Ecthyma is characterized by small, purulent, shallow, punched-out ulcers with thick, brown-black crusts and surrounding erythema o Impetigo and ecthyma cause mild pain or discomfort o Pruritus is common, scratching may spread infection, inoculating adjacent and nonadjacent skin • Management o Remove crusts ▪ Washing with water and soap o Wet dressings with; ▪ Potassium permanganate 1:40000 (0.025%) solution ▪ 0.5% GV paint o Topical therapy (Mupirocin 2%, Fusidic acid, Retapamulin o Systemic antibiotics (if systemic symptoms e.g. pyrexia are present) ▪ Penicillins ▪ Macrolides • Main preventive measure is personal hygiene STEP 3: Folliculitis (25 minutes) • Cause o It is the inflammation of the hair follicle which may be caused by bacteria, fungi, viruses or parasites. o Bacterial folliculitis is usually caused by Staphylococcus aureus and occasionally Pseudomonas aeruginosa ▪ The bacteria enter the hair follicle and cause inflammation • Signs and Symptoms o Mild pain, pruritus, or irritation o Superficial pustule or inflammatory nodule surrounding a hair follicle o Infected hairs easily fall out or are removed, but new papules tend to develop o Deep follicular inflammation often occurs in the bearded areas of the face (Sycosis barbae) • Management o Avoiding suspected irritants o Antiseptics o Topical antibiotics (Neomycin, gentamycin, tetracyclines or mupirocin) o Systemic antibiotics (in systemic manifestations) ▪ Penicillinase resistant penicillins ▪ Clindamycin (topical –lotion or gel) ▪ Cephalosporins • Cephalexin • Main preventive measure is personal hygiene STEP 4: Furunculosis (20 minutes) • Cause and Manifestations o Farunculosis is deep follicular infection that starts as a firm red nodule which rapidly becomes painful and fluctuant in a few days o Furunculosis form furuncles (or boils) that are skin abscesses caused by staphylococcal infection. o Furuncles involve a hair follicle and surrounding tissue o A cluster of furuncles forms a carbuncle. Carbuncles are clusters of furuncles connected subcutaneously, causing deeper suppuration and scarring. o Furuncles are common on the neck, breasts, face, and buttocks o They are uncomfortable and may be painful when closely attached to underlying structures (e.g., on the nose, ear, or fingers) o Appearance is a nodule or pustule that discharges necrotic tissue and sanguineous pus. Carbuncles may be accompanied by fever and prostration • Management o Usually resolves spontaneously, but improved by placing hot compresses over the boil until it breaks o Incision and drainage o Antibiotics (those effective against MRSA) ▪ Clindamycin ▪ Linezolid ▪ Daptomycin ▪ Flucloxacillin ▪ Macrolides e.g. erythromycin STEP 5: Erysipelas (15 minutes) • Cause and Manifestations o Erysipelas is a bacterial infection of upper half of dermis with lymphatic vessel involvement, caused by Group A β-haemolytic Streptococci (rarely by Group C, G and B) o The disease occurs most frequently on the legs and face o Erysipelas begins as a small break in the skin or umbilical stump (infants) o The affected area has growing redness, accompanied by high fever and pains o Erysipelas is characterized clinically by; ▪ Shiny, raised, indurated, and tender plaques with distinct margins ▪ High fever, chills, and malaise • Management o Rest o Lifting affected part o Antiseptics ▪ Potassium permanganate solution 1:4000 o Topical antibiotics ▪ Mupirocin o Systemic antibiotics ▪ Penicillins • Phenoxymethylpenicllin • Amoxycillin ▪ Macrolides • Erythromycin o In recurrent erysipelas treatment should be prolonged (10 to 14 days) STEP 6: Cellulitis (10 minutes) • Cause o Cellulitis is acute bacterial infection of the skin and subcutaneous tissue most often caused by streptococci (S. pyogenes) or staphylococci (S. aureus) o Cellulitis is a deep inflammation and involves lower half of dermis and subcutaneous tissue o Cellulitis differ from erysipelas by; ▪ Raised, sharply demarcated margins from uninvolved skin ▪ Indistinct borders – acute cellulitis and accompanied with systemic symptoms • Signs and Symptoms

Pharmaceutical Sciences Notes, PST Level 5 Semester 1, PST NTA Level 5, PST05103 Pharmaceutical Microbiology

Diseases Caused by Staphylococcal infection and Toxin – PST05103 Pharmaceutical Microbiology

NTA Level 5 • Semester 1 • PST05103 Diseases Caused by Staphylococcal infection and Toxin Pharmaceutical Microbiology • Source Session/Topic 9 Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability. Session 9: Diseases Caused by Staphylococcal infection and Toxin Total Session Time: 60 minutes Pre-requisites • Human anatomy and physiology Students Learning Tasks By the end of this session students are expected to be able to: • Describe common bacterial diseases (causative agents, transmission, signs and symptoms) • Describe treatment, prevention and control of common toxin mediated staphylococcal infection diseases Resources Needed: • Flip charts, marker pens, and masking tape • Black/white board and chalk/whiteboard markers SESSION OVERVIEW |Step |Time |Activity/ |Content | | | |Method | | |1 |5 minutes |Presentation |Introduction, Learning Tasks | |2 | 15 minutes|Presentation |Staphylococcal Food Poisoning | |3 |15 minutes |Presentation |Toxic Shock Syndrome | |4 |15 minutes |Presentation |Signs and Symptoms of Syphilis | |5 |5 minutes |Presentation |Key Points | | 6|5 minutes |Presentation |Evaluation | SESSION CONTENTS STEP 1: Presentation of Session Title and Learning Tasks (5 minutes) READ or ASK students to read the learning tasks and clarify ASK students if they have any questions before continuing STEP 2: Staphylococcal Food Poisoning (15 minutes) • Cause and Transmission o Staphylococcal food poisoning is caused by ingesting food containing a preformed heat-stable staphylococcal enterotoxin o Food can be contaminated by staphylococcal carriers or people with active skin infections o In food that is incompletely cooked or left at room temperature, staphylococci reproduce and elaborate enterotoxin o Many foods can serve as growth media, and despite contamination, they have a normal taste and odor o Common food products are meat, fish, milk or milk products • Signs and Symptoms o Incubation period is 1-8 hours after ingesting contaminated food o Severe nausea and vomiting o Abdominal cramps and diarrhea o Resolves in 24 hours • Treatment and Prevention o Treatment ▪ Symptomatic • Adequate fluids • Rest o Prevention ▪ Refrigeration of food ▪ Hygienic handling of food STEP 3: Toxic Shock Syndrome (15 minutes) • Cause and Transmission o Toxic shock syndrome is a rare, life-threatening complication of certain types of bacterial infections o Often toxic shock syndrome results from toxins produced by Staphylococcus aureus ▪ Staphylococcal Toxic Shock Syndrome (STSS) o Group A streptococci (Streptococcus pyogenes) also produce toxin that causes toxic shock syndrome ▪ Streptococcal toxic shock o Disease occurs following production of exotoxin by the bacteria infecting a wound or colonizing a device or tampon in the body (vaginal tampons or tampon to control nose bleeding) o TSS may also occur following staphylococcal or streptococcal soft tissue infections. The toxin enters bloodstream through skin/mucosal break or via the uterus o Toxic shock syndrome can affect anyone including men, children and postmenopausal women o Women who have preexisting staphylococcal colonization of the vagina and who leave tampons or other devices such as contraceptive sponges or diaphragms in the vagina. o Also, skin wounds and surgery are risk factors for staphylococcal toxic shock syndrome • Signs and Symptoms o Onset of Toxic Shock Syndrome is sudden, with ▪ Fever (39 to 40.5° C, which remains elevated) ▪ Hypotension (which can be refractory) ▪ A diffuse macular erythroderma ▪ Multiple organ dysfunction (involvement of at least 2 other organ systems) o Staphylococcal TSS is likely to cause vomiting, diarrhea, myalgia, mucositis, hepatic damage, thrombocytopenia, and confusion. ▪ Staphylococcal TSS rash is more likely to desquamate, particularly on the palms and soles, between 3 and 7 days after onset o Streptococcal TSS commonly causes acute respiratory distress syndrome (ARDS), coagulopathy, and hepatic damage and is more likely to cause fever, malaise, and severe pain at the site of a soft-tissue infection o Renal impairment is frequent and common to both. The syndrome may progress within 48 h to syncope, shock, and death. Less severe cases of staphylococcal TSS are fairly common • Treatment and Prevention o Local measures ▪ Decontamination • Decontamination includes re-inspection and irrigation of surgical wounds even they appear healthy • Repeated debridement of devitalized tissues • Irrigation of potential naturally colonized sites (sinuses, vagina) o Fluid resuscitation and circulatory support ▪ Fluids and electrolytes are replaced to prevent or treat hypovolemia, hypotension, and shock o Empiric antibiotic therapy ▪ Clindamycin plus vancomycin ▪ Daptomycin ▪ Beta lactamase resistant penicillin e.g. nafcillin, Oxacillin o Preventive measures ▪ Frequent change of tampons ▪ Hygienic wound care ▪ Debridement of infected site STEP 4: Staphylococcal Scalded Skin Syndrome (15 minutes) • Cause and Transmission o Staphylococcal Scalded Skin Syndrome (SSSS) is an acute epidermolysis caused by a staphylococcal toxin o Infants and children are most susceptible o Staphylococcal scalded skin syndrome (SSSS) is caused by coagulase- positive staphylococci which produce a toxin (exfoliatin or epidermolysin) that separate the upper part of epidermis from underlying tissue o The primary infection often begins during the first few days of life in the umbilical stump or diaper area ▪ In older children, the face is the typical site ▪ Toxin produced in these areas enters the circulation and affects the entire skin. • Signs and Symptoms o The initial lesion is usually superficial and crusted o Within 24 hours, the surrounding skin becomes painful and scarlet, changes that quickly spread to other areas o The skin may be exquisitely tender and have a wrinkled tissue paper–like consistency o Large, flaccid blisters arise on the erythematous skin and quickly break to produce erosions o Blisters are frequently present in areas of friction, such as intertriginous areas, buttocks, hands, and feet o Intact blisters extend laterally with gentle pressure (Nikolsky sign) o The epidermis may peel easily, often in large sheets o Widespread desquamation occurs within 36 to 72 hours and patients become very ill with systemic manifestations (e.g. malaise, chills, fever) o Desquamated areas appear scalded o Loss of the protective skin barrier can lead

banner
Scroll to Top